USE OF TRIMETAZIDINE TO INHIBIT ACYL-COA ACETYL TRANSFERASE

摘要

The invention concerns the use of trimetazidine or one of it addition salts to a pharmaceutically acceptable acid to obtain pharmaceutical compositions designed to inhibit acyl-CoA transferase, which can be used for various cardiac and coronary pathologies, for treating angiopathies, intermittent claudication, orientation and equilibrium disorders, age-related maculopathy, diabetic retinopathy or any other pathology related to energy cellular metabolism.